Furthermore, intensive insulin therapy, the primary treatment for T1D, may also encourage weight gain, due to a complex interaction between physiological changes associated with exogenous insulin (such as imbalances in insulin distribution and calorie retention) and psychological adjustments to prevent hypoglycemia (Kueh et al., 2024). The gene discussed is INS; the disease is Hypoglycemia.